Design Therapeutics, Inc. — All Filings
242 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001415889-25-003347 | Feb 7, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-003348 | Feb 7, 2025 | — |
| 3 | — | 0001415889-25-003349 | Feb 7, 2025 | Oct 1, 2024 |
| 8-K | 8-K | 0000950170-25-004612 | Jan 13, 2025 | — |
| 4 | — | 0001415889-25-000880 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000879 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000877 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000878 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-24-029913 | Dec 19, 2024 | Dec 18, 2024 |
| 8-K | 8-K | 0000950170-24-123289 | Nov 7, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-123349 | Nov 7, 2024 | Sep 30, 2024 |
| SC 13D/A | — | 0000935836-24-000514 | Aug 13, 2024 | — |
| 4 | — | 0001415889-24-021086 | Aug 12, 2024 | Aug 9, 2024 |
| 144 | — | 0001178937-24-000042 | Aug 9, 2024 | — |
| 8-K | 8-K | 0000950170-24-090332 | Aug 5, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-090337 | Aug 5, 2024 | Jun 30, 2024 |
| 4 | 4 | 0000950170-24-074363 | Jun 17, 2024 | Jun 13, 2024 |
| 4 | — | 0001415889-24-017241 | Jun 17, 2024 | Jun 13, 2024 |
| 8-K | 8-K | 0000950170-24-074243 | Jun 17, 2024 | Jun 13, 2024 |
| 4 | — | 0001415889-24-017237 | Jun 17, 2024 | Jun 13, 2024 |
| 4 | — | 0001415889-24-017239 | Jun 17, 2024 | Jun 13, 2024 |
| 4 | — | 0001415889-24-017238 | Jun 17, 2024 | Jun 13, 2024 |
| 4 | — | 0001415889-24-017240 | Jun 17, 2024 | Jun 13, 2024 |
| 8-K | 8-K | 0000950170-24-055645 | May 8, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-055788 | May 8, 2024 | Mar 31, 2024 |
| ARS | ARS | 0000950170-24-048411 | Apr 25, 2024 | Dec 31, 2023 |
| DEF 14A | DEF 14A | 0000950170-24-048385 | Apr 25, 2024 | Jun 13, 2024 |
| DEFA14A | DEFA14A | 0000950170-24-048399 | Apr 25, 2024 | — |
| 4 | — | 0001415889-24-009063 | Mar 25, 2024 | Mar 22, 2024 |
| 4 | — | 0001415889-24-009062 | Mar 25, 2024 | — |
| 3 | — | 0001415889-24-008788 | Mar 20, 2024 | Mar 13, 2024 |
| 8-K | 8-K | 0000950170-24-033475 | Mar 19, 2024 | — |
| 10-K | 10-K | 0000950170-24-033492 | Mar 19, 2024 | Dec 31, 2023 |
| S-8 | S-8 | 0000950170-24-033525 | Mar 19, 2024 | — |
| SC 13G/A | AMENDMENT NO. 3 | 0000929638-24-000641 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023960 | Feb 14, 2024 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-24-001042 | Jan 5, 2024 | Jan 2, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-001039 | Jan 5, 2024 | Jan 2, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-057552 | Dec 5, 2023 | Dec 1, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-057548 | Dec 5, 2023 | Dec 1, 2023 |
| SC 13G/A | SC 13G/A | 0001104659-23-118212 | Nov 14, 2023 | — |
| 8-K | 8-K | 0000950170-23-062937 | Nov 13, 2023 | — |
| 10-Q | 10-Q | 0000950170-23-062958 | Nov 13, 2023 | Sep 30, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-051175 | Oct 2, 2023 | Sep 29, 2023 |
| SC 13G/A | — | 0001306550-23-009874 | Sep 7, 2023 | — |
| 4/A | FORM 4/A SUBMISSION | 0001209191-23-048441 | Sep 6, 2023 | Mar 30, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-048222 | Sep 5, 2023 | Sep 1, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-047773 | Aug 30, 2023 | Aug 28, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-047774 | Aug 30, 2023 | Aug 29, 2023 |
| 8-K | 8-K | 0001193125-23-221586 | Aug 25, 2023 | — |